All webinars

Lipid excipients: smart solution for sustained release formulations

  • Modified-release

Understanding the advantages and versatility of using Lipid Excipients for developing Sustained Release Dosage forms. Part I: focus on lipid excipients and their advantages in sustained release formulations. Speaker: Dr. Ketkee Deshmukh, Regional Technical Manager N.India & Nepal, Gattefosse India

lipid-excipients-sustained-release-formulations

Where Do We Stand for Poorly Soluble Drugs and Peptides in Oral Delivery

  • Oral peptides delivery

Speaker: Inayet Ellis of Gattefossé USA and Chris Moreton of FinBrit Consulting

poorly-soluble-drugs-peptides-oral-delivery

Lipid Excipients for Solubility and Bioavailability Enhancement

  • Lipid-based formulations

Speaker: Dr. Agnivesh Shrivastava, Regional Technical Manager – South India & Nepal, Gattefosse India Pvt. Ltd. The talk covered application of lipid excipients in solubility and bioavailability enhancement of poorly water soluble drugs i.e. BCS Class II and IV.

lipid-excipients-solubility-bioavailability-enhancement

3D printing to develop solid lipid-based formulations

  • 3D-printing

The use of three-dimensional printing (3DP) in the development of pharmaceutical dose forms is growing rapidly. However, the studies are exclusively focused on polymer-based systems and very little is known on 3DP for lipid-based formulations. Thus, 3DP was implemented to explore the feasibility of 3DP technology for the development of solid lipid-based formulations.

3d-printing-solid-based-formulations

Strategies for cannabinoids for topical formulations

  • Cannabinoids
  • Skin drug delivery

This webinar will focus on topical dosage forms containing cannabinoids. Practical tips will be given for successful formulation of these highly lipophilic, sensitive active ingredients. Speaker: Ana Gutierrez, Technical Support Manager - Pharmaceuticals Gattefossé SAS

strategies-cannabinoids-topical-formulations

Evidence-based approach for optimizing lipid-based drug delivery systems for oral peptide delivery: Part 2 SEDDS & SMEDDS

  • Oral peptides delivery

In this second part of the presentation Camille explains the rational for using lipid excipients in SEDDS/SMEDDS for the oral delivery of peptides, what features of the formulation are important to protect peptides from degradation in vivo and promote absorption. Speaker: Camille Dumont, PhD, Formulation Scientist

evidence-based-approach-oral-peptide-delivery-part2

Evidence-based approach for optimizing lipid-based systems for oral peptide delivery: part 1 Nanoparticles

  • Oral peptides delivery

In this first presentation of two, Camille describes an industrially relevant production & peptide loading method and techniques applied to characterize nanoparticles to elucidate how to optimize their performance as drug delivery vehicles. Speaker: Camille Dumont, PhD, Formulation Scientist

evidence-based-approach-oral-peptide-delivery-part1

Hot Melt Extrusion: Exploring opportunities for developing Sustained Release formulations using Lipid excipients

  • Modified-release

Understanding the advantages and versatility of using Lipid Excipients for developing Sustained Release Dosage forms. Part III: Processing SR matrices with hot melt extrusion. Speaker: Prof. Purnima Amin, Professor of Pharmacy, Institute of Chemical Technology, India

hot-melt-extrusion-lipid-excipients

Micro or Nano Emulsions for Dermal Route of Administration: How, Where, and When...

  • Skin drug delivery

Learn the practices and caveats of developing microemulsion formulations for drug delivery via the dermal route. Speaker: Jasmine Musakhanian, Scientific & Marketing Director - Pharmaceutical Division, Gatteffossé USA

micro-nano-emulsions-dermal-route-administration